220 related articles for article (PubMed ID: 19032692)
1. C-reactive protein levels and ageing male symptoms in hypogonadal men treated with testosterone supplementation.
Giltay EJ; Haider A; Saad F; Gooren LJ
Andrologia; 2008 Dec; 40(6):398-400. PubMed ID: 19032692
[TBL] [Abstract][Full Text] [Related]
2. Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.
Haider A; Gooren LJ; Padungtod P; Saad F
Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):167-71. PubMed ID: 19472103
[TBL] [Abstract][Full Text] [Related]
3. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome.
Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY
J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.
Ho CC; Tong SF; Low WY; Ng CJ; Khoo EM; Lee VK; Zainuddin ZM; Tan HM
BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057
[TBL] [Abstract][Full Text] [Related]
5. Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial.
Nakhai-Pour HR; Grobbee DE; Emmelot-Vonk MH; Bots ML; Verhaar HJ; van der Schouw YT
Am Heart J; 2007 Dec; 154(6):1228.e1-7. PubMed ID: 18035098
[TBL] [Abstract][Full Text] [Related]
6. Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels.
Gooren LJ; Saad F; Haide A; Yassin A
Andrologia; 2008 Oct; 40(5):298-302. PubMed ID: 18811920
[TBL] [Abstract][Full Text] [Related]
7. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Moisey R; Swinburne J; Orme S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
[TBL] [Abstract][Full Text] [Related]
8. Elevated high sensitivity C-reactive protein levels in aging men with low testosterone.
Kaplan SA; Johnson-Levonas AO; Lin J; Shah AK; Meehan AG
Aging Male; 2010 Jun; 13(2):108-12. PubMed ID: 20001470
[TBL] [Abstract][Full Text] [Related]
9. Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men.
Haider A; Gooren LJ; Padungtod P; Saad F
Andrologia; 2009 Feb; 41(1):7-13. PubMed ID: 19143723
[TBL] [Abstract][Full Text] [Related]
10. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
Kalinchenko SY; Tishova YA; Mskhalaya GJ; Gooren LJ; Giltay EJ; Saad F
Clin Endocrinol (Oxf); 2010 Nov; 73(5):602-12. PubMed ID: 20718771
[TBL] [Abstract][Full Text] [Related]
11. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement therapy for late-onset hypogonadism.
Cunningham GR
Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
[TBL] [Abstract][Full Text] [Related]
13. Variability in total testosterone levels in ageing men with symptoms of androgen deficiency.
Allan CA; Strauss BJ; Forbes EA; Paul E; McLachlan RI
Int J Androl; 2011 Jun; 34(3):212-6. PubMed ID: 20497260
[TBL] [Abstract][Full Text] [Related]
14. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
16. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
Ogbera OA; Sonny C; Olufemi F; Wale A
J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405
[TBL] [Abstract][Full Text] [Related]
17. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
Permpongkosol S; Tantirangsee N; Ratana-olarn K
J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
[TBL] [Abstract][Full Text] [Related]
18. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections.
Rochira V; Balestrieri A; Madeo B; Granata AR; Carani C
J Androl; 2006; 27(2):165-75. PubMed ID: 16278367
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratoristic strategy in late onset hypogonadism.
Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A
Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
